Diethylcarbamazine elicits calcium signals by activation of Brugia malayi TRP-2b channels heterologously expressed in HEK293 cells [PDF]
Diethylcarbamazine is a classic anthelmintic that is used for the prevention and treatment of lymphatic filariasis. The mode of action of diethylcarbamazine is still not well understood with the consensus that it acts on the host immune system, rather ...
Paul D. E. Williams +3 more
doaj +2 more sources
Antifilarial treatment strategies: a systematic review and network meta-analysis [PDF]
Background The World Health Organization (WHO) prescribes mass drug administration (MDA) to eradicate lymphatic filariasis within endemic populations.
Muayad Saud Albadrani +6 more
doaj +2 more sources
Development of diethylcarbamazine-loaded poly(caprolactone) nanoparticles for anti-inflammatory purpose: Preparation and characterization [PDF]
Diethylcarbamazine-loaded nanoparticles were previously evaluated for their anti-inflammatory activity. However, little is known regarding their physicochemical properties.
Henrique Rodrigues Marcelino +8 more
doaj +2 more sources
Diagnosis of O. volvulus infection via skin exposure to diethylcarbamazine: clinical evaluation of a transdermal delivery technology-based patch [PDF]
Background Elimination of onchocerciasis in Africa is now regarded as an achievable goal in many areas. This makes monitoring changes in infection prevalence a key component of control programmes. Monitoring is currently based on determining the presence
K. Awadzi +4 more
doaj +2 more sources
Diethylcarbamazine (Hetrazan) in Experimental Trichinosis [PDF]
The general acceptance of diethylcarbamazine or Hetrazan (1-diethylcarbamyl-4-methylpiperazine hydrochloride [or dihydrogen citrate]) as a useful drug in the treatment of filarial diseases caused by several types of worm and affecting various animals, including man, has stimulated its trial in treatment of other nematode infections. It has been claimed
T B, MAGATH, J H, THOMPSON
openaire +3 more sources
Treatment of loiasis: a review of clinical management recommendations [PDF]
Background Loiasis affects more than 20 million residents of endemic regions in Central and West Africa causing chronic and often lifelong disease. Antifilarial treatment options for loiasis include diethylcarbamazine, ivermectin, and albendazole.
Dorothea Ekoka Mbassi +6 more
doaj +2 more sources
Coverage evaluation of mass drug administration for lymphatic filariasis in four endemic districts of Jharkhand, India [PDF]
Background Lymphatic filariasis (LF) remains endemic in several districts of Jharkhand despite repeated Mass Drug Administration (MDA) rounds. This study assessed drug coverage, compliance, and associated factors in four endemic districts: Deoghar, Dumka,
Bijit Biswas +4 more
doaj +2 more sources
Diethylcarbamazine and Non-Diethylcarbamazine Related Bancroftian Granuloma: An Immunohistochemical Study of Eosinophil Toxic Proteins [PDF]
It has been suggested, mostly using in vitro experiments, that defenses against parasites involve mainly activated eosinophils and their toxic proteins, such as major basic protein (MBP), eosinophil cationic protein (ECP) and eosinophil peroxidase (EPO).
Jose, Figueredo-Silva +4 more
openaire +3 more sources
A low-tech analytical method for diethylcarbamazine citrate in medicated salt. [PDF]
The World Health Organization has called for an effort to eliminate Lymphatic Filariasis (LF) around the world. In regions where the disease is endemic, local production and distribution of medicated salt dosed with diethylcarbamazine (DEC) has been an ...
Abigail Weaver +7 more
doaj +3 more sources
Diethylcarbamazine (DEC) is the first-line drug for the control and treatment of lymphatic filariasis caused by the Wuchereria bancrofti and Brugia malayi parasite. DEC is rapidly and extensively metabolised in the liver.
W Ridtitid +5 more
doaj +2 more sources

